about
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several ne...
Read More
202.71
-2.32
(-1.13%)
6.7M
XNYS Volume
XNYS 07 May, 2026 5:30 PM (EDT)
Board Meeting
The board meeting for AbbVie is scheduled for today, for the purpose of AbbVie Inc Annual General Meeting for 2026
See details
Not Eligible
Expensive Valuation
Technically Neutral
AbbVie Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..